Benzodiazepine Prescribing in Delaware
Medicare Part D, 2013–2024.
Benzodiazepine prescribing in Delaware fell 11.2% between 2013 and 2024 — a slower fall than the country as a whole. In 2024 the state recorded 102,142 Medicare Part D benzodiazepine claims across 25,348 patients, an average of 4.03 fills per patient per year, which ranks 44 of 51 states. Alprazolam accounts for 40.7% of it.
Delaware over twelve years
Which benzodiazepines Delaware prescribes
| Drug | Claims 2024 | Share |
|---|---|---|
| Alprazolam | 41,620 | 40.7% |
| Clonazepam | 23,911 | 23.4% |
| Lorazepam | 21,918 | 21.5% |
| Diazepam | 10,525 | 10.3% |
| Temazepam | 3,535 | 3.5% |
Psychiatric prescribers in Delaware
78 psychiatric prescribers in Delaware appear in the 2024 Medicare Part D data with benzodiazepine claims. 10 of them recorded at least a 50% fall in benzodiazepine claims since 2019. Sorted by change, largest reduction first.
This is a record, not a recommendation. A fall in Medicare benzodiazepine claims has many possible explanations — a changing patient panel, retirement, a shift to another payer, or simply dropping below the threshold CMS publishes. It does not establish that a prescriber supports tapering, and a low number does not mean they will take you as a patient. Use it as one input, then ask the five vetting questions.
| Prescriber | City | 2019 | 2024 | Change |
|---|---|---|---|---|
| Parth VirojaPsychiatry | Newark | 367 | 14 | -96.2% |
| Robert CohnPsychiatry | Wilmington | 262 | 11 | -95.8% |
| Anis AhmedPsychiatry | Millsboro | 1,101 | 138 | -87.5% |
| Alexander JacobsonPsychiatry | Newark | 65 | 11 | -83.1% |
| Joseph BryerPsychiatry | Wilmington | 414 | 81 | -80.4% |
| Charles DickPsychiatry | Newark | 66 | 19 | -71.2% |
| David KalksteinPsychiatry | Wilmington | 972 | 303 | -68.8% |
| Rabia QaziPsychiatry | Newark | 139 | 44 | -68.3% |
| Robert GorkinPsychiatry | Dover | 33 | 11 | -66.7% |
| Ranga RamPsychiatry | Wilmington | 486 | 183 | -62.3% |
| Chandrakala KathiravanPsychiatry | Wilmington | 230 | 121 | -47.4% |
| Praful DesaiPsychiatry | Newark | 26 | 15 | -42.3% |
| Lynne HagelinPsychiatry | Wilmington | 235 | 142 | -39.6% |
| Nathan CentersPsychiatry & Neurology | Wilmington | 41 | 25 | -39% |
| Gerald MehalickPsychiatry | Wilmington | 177 | 111 | -37.3% |
| Heather KennedyPsychiatry & Neurology | Wilmington | 152 | 119 | -21.7% |
| Mustafa MuftiPsychiatry | New Castle | 103 | 82 | -20.4% |
| Judith MarcusPsychiatry | Wilmington | 152 | 123 | -19.1% |
| James EllisonPsychiatry | Wilmington | 154 | 131 | -14.9% |
| Norman BroudyPsychiatry | Wilmington | 158 | 139 | -12% |
| Mark BorerPsychiatry | Dover | 68 | 60 | -11.8% |
| Sandeep GuptaPsychiatry | Wilmington | 1,211 | 1,070 | -11.6% |
| Melody BensonPsychiatry | Lewes | 120 | 109 | -9.2% |
| Tracee BurroughsPsychiatry | Wilmington | 24 | 22 | -8.3% |
| Dilipkumar JoshiPsychiatry | Newark | 542 | 501 | -7.6% |
| Jose CapiroPsychiatry | Wilmington | 51 | 48 | -5.9% |
| Andrew DonohuePsychiatry | Wilmington | 799 | 775 | -3% |
| David NixonPsychiatry | Dover | 1,036 | 1,019 | -1.6% |
| Ramnik SinghPsychiatry | Wilmington | 416 | 410 | -1.4% |
| Ivan CohenPsychiatry | Newark | 366 | 363 | -0.8% |
| Carol TavaniPsychiatry | Wilmington | 89 | 89 | 0% |
| Ujwala DixitPsychiatry | Wilmington | 12 | 12 | 0% |
| Richard CruzPsychiatry | Wilmington | 35 | 36 | +2.9% |
| Fawzia HasanPsychiatry | Wilmington | 630 | 662 | +5.1% |
| Kathlyn RowenPsychiatry | Wilmington | 820 | 870 | +6.1% |
| Nana BerikashviliPsychiatry | Wilmington | 708 | 816 | +15.3% |
| Adeel NasirPsychiatry | New Castle | 120 | 139 | +15.8% |
| Manisha WadhwaPsychiatry | Wilmington | 385 | 458 | +19% |
| Kisun LeePsychiatry | Wilmington | 79 | 99 | +25.3% |
| Barry GoldsteinNeuropsychiatry | Dover | 21 | 30 | +42.9% |
| Jeet JoshiPsychiatry | Newark | 128 | 191 | +49.2% |
| Meriam ChuaPsychiatry | Dover | 484 | 762 | +57.4% |
| Nadeem AfzalPsychiatry | New Castle | 69 | 124 | +79.7% |
| Sehba Husain-KrautterPsychiatry & Neurology | New Castle | 18 | 39 | +116.7% |
| Neil KayePsychiatry & Neurology | Wilmington | 18 | 42 | +133.3% |
| Sharon ZwillingerPsychiatry & Neurology | Hockessin | 28 | 80 | +185.7% |
| Jolomi IkomiPsychiatry | Wilmington | 15 | 44 | +193.3% |
| Andrew PittsPsychiatry & Neurology | Lewes | 29 | 87 | +200% |
| Nicoleta CoconceaPsychiatry | Wilmington | 44 | 172 | +290.9% |
| Patricia LifrakPsychiatry | New Castle | 35 | 258 | +637.1% |
| Victor RendonPsychiatry & Neurology | Wilmington | — | 193 | — |
| Berjees MukhtarPsychiatry | Middletown | — | 187 | — |
| Mian Zarshawn JanPsychiatry & Neurology | Wilmington | — | 176 | — |
| Vanessa PatelPsychiatry | Wilmington | — | 175 | — |
| John JohnsonPsychiatry | New Castle | — | 156 | — |
| Ellen MinervaPsychiatry | Wilmington | — | 135 | — |
| Kanida CharuwornPsychiatry | New Castle | — | 132 | — |
| Sarah FalgowskiPsychiatry & Neurology | Wilmington | — | 125 | — |
| Shashi PrabhaPsychiatry | Wilmington | — | 120 | — |
| Deniz EkerPsychiatry | Wilmington | — | 99 | — |
| Thaddeaus FosterPsychiatry | New Castle | — | 95 | — |
| Immad KianiPsychiatry | Wilmington | — | 87 | — |
| Kathryn ShirleyPsychiatry & Neurology | Newark | — | 85 | — |
| Sana SharmaPsychiatry | Wilmington | — | 80 | — |
| Nurun BegumPsychiatry | Dover | — | 72 | — |
| Jack CastroPsychiatry & Neurology | Wilmington | — | 69 | — |
| Imran TrimziPsychiatry | Wilmington | — | 52 | — |
| Janis ChesterPsychiatry & Neurology | Dover | — | 40 | — |
| Jacob BlyPsychiatry & Neurology | Newark | — | 34 | — |
| Constantine AzarconPsychiatry & Neurology | Wilmington | — | 22 | — |
| Subani MaheshwariPsychiatry | Wilmington | — | 21 | — |
| Lara JaradatPsychiatry | Wilmington | — | 17 | — |
| Eric ZhangPsychiatry & Neurology | Newark | — | 16 | — |
| Phyllis SmoyerPsychiatry & Neurology | Claymont | — | 14 | — |
| Vishesh AgarwalPsychiatry | Wilmington | — | 11 | — |
| Shahid HussainPsychiatry | Newark | 13 | 150 | +1053.8% |
| David HanawayPsychiatry | Wilmington | 16 | 301 | +1781.2% |
| John McgrawPsychiatry | Georgetown | 18 | 394 | +2088.9% |
Figures are reproduced from the CMS public use files without alteration. Clinicians who believe a row misstates their record can write to support@taperoffbenzos.com and we will check it against the source file and correct or remove it.
Finding a prescriber in Delaware
This data describes prescribing patterns; it does not tell you who will support a slow taper. For that, our guide to finding a benzo-wise prescriber compares every free provider directory that exists and lists the five questions that predict how a taper will go. If you already have a prescriber, the taper calculator generates a schedule to review with them.
Frequently asked questions
Is benzodiazepine prescribing rising or falling in Delaware?
It fell 11.2% between 2013 and 2024 in Medicare Part D — a slower fall than the country as a whole, where prescribing fell 12.9%. In 2024, Delaware recorded 102,142 benzodiazepine claims across 25,348 patients.
How does Delaware compare to other states?
Delaware ranks 44 of 51 for prescribing intensity, at 4.03 benzodiazepine fills per patient per year, and 27 of 51 for the size of its decline since 2013 (1 being the steepest fall).
Which benzodiazepine is prescribed most in Delaware?
Alprazolam, at 41,620 claims — 40.7% of the state's benzodiazepine prescribing in 2024. Next are Clonazepam (23.4%) and Lorazepam (21.5%).
Source
CMS Medicare Part D Prescribers public use files, data years 2013–2024 (US Government work, public domain). Medicare Part D only — it excludes commercial insurance and cash-pay, skews toward patients 65 and over, and suppresses cells of 10 or fewer claims. Full methodology and limitations are on the national page.